These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18775614)

  • 1. Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.
    Fontanges T; Bailly F; Trepo E; Chevallier M; Maynard-Muet M; Nalet B; Beorchia S; Pillon D; Moindrot H; Froissart B; Slaoui M; Tinel X; Pradat P; Trepo C
    Gastroenterol Clin Biol; 2008 Oct; 32(10):858-65. PubMed ID: 18775614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of FibroTest-ActiTest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis B and C.
    Uyar C; Akcam FZ; Ciris M; Kaya O; Kockar C; Isler M
    Indian J Pathol Microbiol; 2010; 53(3):470-5. PubMed ID: 20699505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.
    El-Shabrawi MH; Mohsen NA; Sherif MM; El-Karaksy HM; Abou-Yosef H; El-Sayed HM; Riad H; Bahaa N; Isa M; El-Hennawy A
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):946-51. PubMed ID: 20110820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C.
    Canbakan M; Senturk H; Canbakan B; Toptas T; Tabak O; Ozaras R; Tabak F; Balcı H; Sut N; Ozbay G
    Nephron Clin Pract; 2011; 117(3):c289-95. PubMed ID: 20847572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
    Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux".
    Munteanu M; Lebray P; Massard J; Moussalli J; Varaut A; Ngo Y; Thabut D; Imbert-Bismut F; Benhamou Y; Ratziu V; Poynard T
    Gastroenterol Clin Biol; 2009 Feb; 33(2):133-4. PubMed ID: 19193507
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
    Zarski JP; Sturm N; Guechot J; Paris A; Zafrani ES; Asselah T; Boisson RC; Bosson JL; Guyader D; Renversez JC; Bronowicki JP; Gelineau MC; Tran A; Trocme C; De Ledinghen V; Lasnier E; Poujol-Robert A; Ziegler F; Bourliere M; Voitot H; Larrey D; Rosenthal-Allieri MA; Fouchard Hubert I; Bailly F; Vaubourdolle M;
    J Hepatol; 2012 Jan; 56(1):55-62. PubMed ID: 21781944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
    Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
    Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
    Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure.
    Poynard T; Munteanu M; Ngo Y; Castera L; Halfon P; Ratziu V; Imbert-Bismut F; Thabut D; Bourliere M; Cacoub P; Messous D; de Ledinghen V
    Gastroenterol Clin Biol; 2010; 34(6-7):388-96. PubMed ID: 20580175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
    Cross TJ; Rizzi P; Berry PA; Bruce M; Portmann B; Harrison PM
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):730-8. PubMed ID: 19430302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
    Poynard T; Zoulim F; Ratziu V; Degos F; Imbert-Bismut F; Deny P; Landais P; El Hasnaoui A; Slama A; Blin P; Thibault V; Parvaz P; Munteanu M; Trepo C
    Am J Gastroenterol; 2005 Sep; 100(9):1970-80. PubMed ID: 16128941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.
    Leroy V; Sturm N; Faure P; Trocme C; Marlu A; Hilleret MN; Morel F; Zarski JP
    J Hepatol; 2014 Jul; 61(1):28-34. PubMed ID: 24631902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.